دورية أكاديمية
أعرض في EDS

Proceedings of the 10th annual deep brain stimulation think tank: Advances in cutting edge technologies, artificial intelligence, neuromodulation, neuroethics, interventional psychiatry, and women in neuromodulation.

التفاصيل البيبلوغرافية
العنوان: Proceedings of the 10th annual deep brain stimulation think tank: Advances in cutting edge technologies, artificial intelligence, neuromodulation, neuroethics, interventional psychiatry, and women in neuromodulation.
المؤلفون: Wong JK; Department of Neurology, Fixel Institute for Neurological Diseases, University of Florida, Gainesville, FL, United States., Mayberg HS; Department of Neurology, Neurosurgery, Psychiatry, and Neuroscience, Icahn School of Medicine at Mount Sinai, New York, NY, United States., Wang DD; Department of Neurological Surgery, Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA, United States., Richardson RM; Department of Neurosurgery, Massachusetts General Hospital and Harvard Medical School, Boston, MA, United States., Halpern CH; Richards Medical Research Laboratories, Department of Neurosurgery, Perelman School of Medicine, Pennsylvania Hospital, University of Pennsylvania, Philadelphia, PA, United States., Krinke L; Newronika, Goose Creek, SC, United States.; Department of Neuroscience, West Virginia University, Morgantown, WV, United States., Arlotti M; Newronika, Goose Creek, SC, United States., Rossi L; Newronika, Goose Creek, SC, United States., Priori A; Newronika, Goose Creek, SC, United States., Marceglia S; Newronika, Goose Creek, SC, United States., Gilron R; Rune Labs, San Francisco, CA, United States., Cavanagh JF; Department of Psychology, University of New Mexico, Albuquerque, NM, United States., Judy JW; Department of Electrical and Computer Engineering, University of Florida, Gainesville, FL, United States., Miocinovic S; Department of Neurology, School of Medicine, Emory University, Atlanta, GA, United States., Devergnas AD; Department of Neurology, School of Medicine, Emory University, Atlanta, GA, United States., Sillitoe RV; Department of Neuroscience, Baylor College of Medicine, Houston, TX, United States., Cernera S; Department of Neurological Surgery, Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA, United States., Oehrn CR; Department of Neurological Surgery, Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA, United States., Gunduz A; J. Crayton Pruitt Family Department of Biomedical Engineering, University of Florida, Gainesville, FL, United States., Goodman WK; Department of Psychiatry and Behavioral Sciences, Baylor College of Medicine, Houston, TX, United States., Petersen EA; Department of Neurosurgery, University of Arkansas for Medical Sciences, Little Rock, AR, United States., Bronte-Stewart H; Department of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, CA, United States., Raike RS; Restorative Therapies Group Implantables, Research, and Core Technology, Medtronic Inc., Minneapolis, MN, United States., Malekmohammadi M; Boston Scientific Neuromodulation Corporation, Valencia, CA, United States., Greene D; NeuroPace, Inc., Mountain View, CA, United States., Heiden P; Department of Stereotactic and Functional Neurosurgery, Faculty of Medicine, University Hospital Cologne, University of Cologne, Cologne, Germany., Tan H; Medical Research Council Brain Network Dynamics Unit, Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, United Kingdom., Volkmann J; Department of Neurology, University of Würzburg, Würzburg, Germany., Voon V; Department of Psychiatry, University of Cambridge, Cambridge, United Kingdom., Li L; National Engineering Research Center of Neuromodulation, School of Aerospace Engineering, Tsinghua University, Beijing, China., Sah P; Queensland Brain Institute, University of Queensland, St Lucia, QLD, Australia., Coyne T; Queensland Brain Institute, University of Queensland, St Lucia, QLD, Australia., Silburn PA; Queensland Brain Institute, University of Queensland, St Lucia, QLD, Australia., Kubu CS; Department of Neurology, Cleveland Clinic, Cleveland, OH, United States., Wexler A; Department of Medical Ethics and Health Policy, University of Pennsylvania, Philadelphia, PA, United States., Chandler J; Centre for Health Law, Policy, and Ethics, Faculty of Law, University of Ottawa, Ottawa, ON, Canada., Provenza NR; Department of Neurosurgery, Baylor College of Medicine, Houston, TX, United States., Heilbronner SR; Department of Neuroscience, University of Minnesota, Minneapolis, MN, United States., Luciano MS; Department of Neurology, Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA, United States., Rozell CJ; School of Electrical and Computer Engineering, Georgia Institute of Technology, Atlanta, GA, United States., Fox MD; Center for Brain Circuit Therapeutics, Department of Neurology, Psychiatry, Radiology, and Neurosurgery, Brigham and Women's Hospital, Boston, MA, United States., de Hemptinne C; Department of Neurology, Fixel Institute for Neurological Diseases, University of Florida, Gainesville, FL, United States., Henderson JM; Department of Neurosurgery, Stanford University, Stanford, CA, United States., Sheth SA; Department of Neurosurgery, Baylor College of Medicine, Houston, TX, United States., Okun MS; Department of Neurology, Fixel Institute for Neurological Diseases, University of Florida, Gainesville, FL, United States.
المصدر: Frontiers in human neuroscience [Front Hum Neurosci] 2023 Jan 27; Vol. 16, pp. 1084782. Date of Electronic Publication: 2023 Jan 27 (Print Publication: 2022).
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: Frontiers Research Foundation Country of Publication: Switzerland NLM ID: 101477954 Publication Model: eCollection Cited Medium: Print ISSN: 1662-5161 (Print) Linking ISSN: 16625161 NLM ISO Abbreviation: Front Hum Neurosci Subsets: PubMed not MEDLINE
أسماء مطبوعة: Original Publication: Lausanne, Switzerland : Frontiers Research Foundation, 2008-
مستخلص: The deep brain stimulation (DBS) Think Tank X was held on August 17-19, 2022 in Orlando FL. The session organizers and moderators were all women with the theme women in neuromodulation . Dr. Helen Mayberg from Mt. Sinai, NY was the keynote speaker. She discussed milestones and her experiences in developing depression DBS. The DBS Think Tank was founded in 2012 and provides an open platform where clinicians, engineers and researchers (from industry and academia) can freely discuss current and emerging DBS technologies as well as the logistical and ethical issues facing the field. The consensus among the DBS Think Tank X speakers was that DBS has continued to expand in scope however several indications have reached the "trough of disillusionment." DBS for depression was considered as "re-emerging" and approaching a slope of enlightenment. DBS for depression will soon re-enter clinical trials. The group estimated that globally more than 244,000 DBS devices have been implanted for neurological and neuropsychiatric disorders. This year's meeting was focused on advances in the following areas: neuromodulation in Europe, Asia, and Australia; cutting-edge technologies, closed loop DBS, DBS tele-health, neuroethics, lesion therapy, interventional psychiatry, and adaptive DBS.
Competing Interests: HM received consulting and IP licensing fees from Abbott Labs. WG received consulting fees from Biohaven and royalties from Nview, LLC and OCDscales, and LLC. EP had received research support from Mainstay, Medtronic, Neuros Medical, Nevro Corp, ReNeuron, SPR, and Saluda, personal fees from Abbott Neuromodulation, Biotronik, Medtronic Neuromodulation, Nalu, Neuros Medical, Nevro, Presidio Medical, Saluda, and Vertos, and holds stock options from SynerFuse and Neuro42. JV had received consulting fees and grant support by Medtronic and Boston Scientific both manufacturers of DBS systems, consulting fees by Newronika and CereGate and honoraria for lecturing by Abbott. JH was a consultant for Neuralink and serves on the Medical Advisory Board of Enspire DBS. SS was a consultant for Boston Scientific, Zimmer Biomet, NeuroPace, Koh Young, and is a co-founder of Motif Neurotech. RSR was employed by Medtronic Inc. MM was employed by Boston Scientific Neuromodulation Corporation. DG was employed by NeuroPace, Inc. LK, MA, LR, SMa, and AP were employed by Newronika. RG was employed by Rune Labs. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
(Copyright © 2023 Wong, Mayberg, Wang, Richardson, Halpern, Krinke, Arlotti, Rossi, Priori, Marceglia, Gilron, Cavanagh, Judy, Miocinovic, Devergnas, Sillitoe, Cernera, Oehrn, Gunduz, Goodman, Petersen, Bronte-Stewart, Raike, Malekmohammadi, Greene, Heiden, Tan, Volkmann, Voon, Li, Sah, Coyne, Silburn, Kubu, Wexler, Chandler, Provenza, Heilbronner, Luciano, Rozell, Fox, de Hemptinne, Henderson, Sheth and Okun.)
References: J Neurosci. 2019 Apr 3;39(14):2698-2708. (PMID: 30700532)
eNeuro. 2022 Nov 11;9(6):. (PMID: 36270803)
Clin Neurophysiol Pract. 2022 Mar 10;7:103-106. (PMID: 35345863)
Epilepsia. 2017 Apr;58(4):522-530. (PMID: 28276060)
J Physiol. 2021 Apr;599(7):2037-2054. (PMID: 33369735)
Front Hum Neurosci. 2021 Jan 13;14:588458. (PMID: 33519399)
Natl Sci Rev. 2022 May 24;9(10):nwac099. (PMID: 36196114)
Front Hum Neurosci. 2021 Apr 19;15:644593. (PMID: 33953663)
Brain Stimul. 2020 Nov - Dec;13(6):1784-1792. (PMID: 33038597)
Annu Int Conf IEEE Eng Med Biol Soc. 2021 Nov;2021:6159-6162. (PMID: 34892522)
NPJ Parkinsons Dis. 2022 Jul 8;8(1):88. (PMID: 35804160)
J Neurosurg. 2020 Feb 7;:1-10. (PMID: 32032944)
J Neurol Neurosurg Psychiatry. 2022 Sep 20;:. (PMID: 36127157)
J Neurolinguistics. 2021 Nov;60:. (PMID: 34305315)
JAMA Neurol. 2013 Jan;70(1):85-94. (PMID: 23044532)
Brain. 2011 Mar;134(Pt 3):832-44. (PMID: 21354977)
Mov Disord. 2016 Nov;31(11):1748-1751. (PMID: 27548068)
Exp Neurol. 2022 Oct;356:114150. (PMID: 35732220)
Brain Stimul. 2019 Jul - Aug;12(4):868-876. (PMID: 30833216)
J Neurosurg. 2017 Jan;126(1):122-131. (PMID: 26918474)
Neurodegener Dis Manag. 2021 Aug;11(4):315-328. (PMID: 34261338)
iScience. 2022 Mar 04;25(4):104028. (PMID: 35313697)
Cell Rep. 2022 Mar 8;38(10):110477. (PMID: 35263607)
Mol Psychiatry. 2022 Aug;27(8):3374-3384. (PMID: 35697760)
J Neural Eng. 2022 Aug 18;19(4):. (PMID: 35921806)
Brain Stimul. 2021 May-Jun;14(3):549-563. (PMID: 33757931)
Nat Biotechnol. 2021 Sep;39(9):1078-1085. (PMID: 33941932)
BMJ Open. 2022 Jan 03;12(1):e049955. (PMID: 34980610)
Front Neurosci. 2021 Oct 18;15:732499. (PMID: 34733132)
N Engl J Med. 2001 Oct 18;345(16):1184-92. (PMID: 11642235)
Cereb Cortex. 2022 Mar 30;32(7):1337-1349. (PMID: 34470045)
Neuromodulation. 2023 Feb;26(2):414-423. (PMID: 35570149)
Proc Natl Acad Sci U S A. 2018 Jan 2;115(1):192-197. (PMID: 29255043)
Nat Med. 2021 Dec;27(12):2154-2164. (PMID: 34887577)
Biol Psychiatry. 2022 Sep 16;:. (PMID: 36123196)
Front Neurol. 2021 Nov 08;12:785529. (PMID: 34819915)
IEEE Trans Neural Syst Rehabil Eng. 2017 Dec;25(12):2217-2226. (PMID: 28113981)
Biosens Bioelectron. 2021 Mar 15;176:112888. (PMID: 33395569)
Cerebellum. 2022 Oct;21(5):762-775. (PMID: 35218525)
Nat Biomed Eng. 2022 Jun;6(6):706-716. (PMID: 35361934)
J Neurosci. 2022 Apr 13;42(15):3228-3240. (PMID: 35232766)
Ann Neurol. 2020 Dec;88(6):1178-1193. (PMID: 32951262)
Nat Rev Neurol. 2011 Nov 08;7(12):667-76. (PMID: 22064610)
JAMA Neurol. 2022 Oct 1;79(10):1064-1068. (PMID: 36094652)
Lancet Neurol. 2009 May;8(5):464-74. (PMID: 19375664)
PLoS One. 2018 Nov 21;13(11):e0204566. (PMID: 30462658)
Neuromodulation. 2022 Feb;25(2):271-275. (PMID: 35125146)
J Parkinsons Dis. 2021;11(4):1887-1899. (PMID: 34151855)
J Neurol Neurosurg Psychiatry. 2020 May;91(5):533-539. (PMID: 32139653)
Nat Med. 2015 Oct;21(10):1142-5. (PMID: 26413781)
Front Hum Neurosci. 2021 Sep 06;15:717401. (PMID: 34552476)
Brain Stimul. 2019 Mar - Apr;12(2):344-352. (PMID: 30514614)
Parkinsonism Relat Disord. 2021 Mar;84:47-51. (PMID: 33556765)
Nat Commun. 2020 Jul 3;11(1):3364. (PMID: 32620886)
Front Neurosci. 2021 Dec 07;15:763235. (PMID: 34949982)
J Neurosci. 2018 Jun 13;38(24):5620-5631. (PMID: 29789378)
Front Neurol. 2021 Oct 20;12:769275. (PMID: 34744993)
J Neurosci. 2018 Oct 24;38(43):9129-9141. (PMID: 30201770)
Neuron. 2020 May 20;106(4):579-588.e3. (PMID: 32155442)
Neuroimage. 2022 Apr 15;250:118962. (PMID: 35121181)
Front Hum Neurosci. 2022 Mar 04;16:813387. (PMID: 35308605)
J Leg Med. 2019 Oct-Dec;39(4):335-399. (PMID: 31940252)
Front Neurosci. 2021 Apr 12;15:637274. (PMID: 33912002)
J Mov Disord. 2020 Sep;13(3):185-198. (PMID: 32854482)
J Bioeth Inq. 2019 Jun;16(2):237-248. (PMID: 30741392)
Neurology. 2018 Mar 13;90(11):e971-e976. (PMID: 29444973)
Neurosurgery. 2021 Apr 15;88(5):E420-E426. (PMID: 33575799)
Brain. 2022 May 24;145(4):1410-1421. (PMID: 35037938)
Mov Disord. 2020 Jan;35(1):91-100. (PMID: 31348550)
Expert Rev Med Devices. 2021 Apr;18(4):319-332. (PMID: 33765395)
Brain. 2019 Nov 1;142(11):3592-3604. (PMID: 31553039)
Contemp Clin Trials Commun. 2021 Jun 05;22:100785. (PMID: 34189335)
Brain Stimul. 2021 Sep-Oct;14(5):1109-1117. (PMID: 34352356)
Ann Neurol. 2013 Sep;74(3):449-57. (PMID: 23852650)
Front Neurol. 2022 Aug 09;13:909264. (PMID: 36016538)
Acta Neurochir (Wien). 2021 Jan;163(1):205-209. (PMID: 32710183)
Eur J Neurol. 2021 Jul;28(7):2372-2377. (PMID: 33675144)
Cerebellum. 2022 Jul 12;:. (PMID: 35821365)
Nature. 2021 May;593(7858):249-254. (PMID: 33981047)
Dis Model Mech. 2022 Sep 1;15(9):. (PMID: 35972048)
NPJ Parkinsons Dis. 2022 Apr 19;8(1):44. (PMID: 35440571)
Parkinsonism Relat Disord. 2016 Aug;29:35-41. (PMID: 27297737)
Brain. 2012 May;135(Pt 5):1463-77. (PMID: 22508959)
J Neurosurg. 2018 Aug;129(2):308-314. (PMID: 28960154)
Elife. 2017 Feb 21;6:. (PMID: 28220753)
J Neural Eng. 2021 Aug 31;18(4):. (PMID: 34388744)
Front Hum Neurosci. 2021 Aug 13;15:702961. (PMID: 34483867)
Am J Psychiatry. 2021 Jan 1;178(1):17-29. (PMID: 33384007)
IEEE Trans Neural Syst Rehabil Eng. 2018 Aug;26(8):1618-1625. (PMID: 29994714)
J Med Internet Res. 2019 Oct 31;21(10):e16194. (PMID: 31642810)
Neuroimage. 2019 Sep;198:137-149. (PMID: 31077843)
N Engl J Med. 2008 Nov 13;359(20):2121-34. (PMID: 19005196)
Neuropsychopharmacology. 2019 Jun;44(7):1224-1232. (PMID: 30867553)
J Neural Eng. 2022 Jul 20;19(4):. (PMID: 35790135)
PLoS One. 2016 Aug 09;11(8):e0160750. (PMID: 27504631)
J Neurophysiol. 2019 Jun 1;121(6):2336-2340. (PMID: 31017846)
Brain. 2006 Dec;129(Pt 12):3366-75. (PMID: 17077105)
Brain Stimul. 2022 May-Jun;15(3):747-749. (PMID: 35526817)
Mov Disord. 2018 Mar;33(3):421-430. (PMID: 29465787)
معلومات مُعتمدة: R01 NS100874 United States NS NINDS NIH HHS; R01 NS096008 United States NS NINDS NIH HHS; RF1 MH123407 United States MH NIMH NIH HHS; UH3 NS103550 United States NS NINDS NIH HHS; R01 NS119301 United States NS NINDS NIH HHS; R01 DC014034 United States DC NIDCD NIH HHS; UH3 NS100544 United States NS NINDS NIH HHS; R01 MH119382 United States MH NIMH NIH HHS; K23 NS097576 United States NS NINDS NIH HHS; R25 NS108939 United States NS NINDS NIH HHS; R01 MH114853 United States MH NIMH NIH HHS; UH2 NS095548 United States NS NINDS NIH HHS; KL2 TR001429 United States TR NCATS NIH HHS; UH3 NS100549 United States NS NINDS NIH HHS; United Kingdom WT_ Wellcome Trust; U01 NS098968 United States NS NINDS NIH HHS; R01 NR014852 United States NR NINR NIH HHS; RC1 NS068086 United States NS NINDS NIH HHS; P50 HD103555 United States HD NICHD NIH HHS; K23 NS099441 United States NS NINDS NIH HHS; UH3 NS107709 United States NS NINDS NIH HHS; U01 DC017844 United States DC NIDCD NIH HHS; R01 NS127435 United States NS NINDS NIH HHS
فهرسة مساهمة: Keywords: Parkinson’s disease; adaptive DBS; artificial intelligence; deep brain stimulation (DBS); dystonia; epilepsy; interventional psychiatry; neuroethics
تواريخ الأحداث: Date Created: 20230223 Latest Revision: 20240426
رمز التحديث: 20240426
مُعرف محوري في PubMed: PMC9933515
DOI: 10.3389/fnhum.2022.1084782
PMID: 36819295
قاعدة البيانات: MEDLINE
الوصف
تدمد:1662-5161
DOI:10.3389/fnhum.2022.1084782